New drug hailed a 'game changer' for cancer patients



An immunotherapy drug could soon offer new hope to patients with currently untreatable head and neck cancers.
Nivolumab was hailed a potential "game changer" after it was found to extend the lives of relapsed patients who had run out of therapy options.
After a year of treatment, 36% of trial patients treated with the drug were still alive compared with 17% of those given standard chemotherapy.
Patients with advanced head and neck cancers resistant to chemotherapy are notoriously difficult to treat and generally survive less than six months.
Trial participants treated with... read more

 
9 October 2016 in Regional East, Views: 29
Source: Belper News
Share:
  •  





    News Widget for Webmasters



    Bring Eugene's son back home immediately

    Realtime News

     

    «
    »
    Mo Tu We Th Fr Sa Su
          1 2 3 4
    5 6 7 8 9 10 11
    12 13 14 15 16 17 18
    19 20 21 22 23 24 25
    26 27 28 29 30 31